Tickers

TMUS — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 06:41:40.047294 UTC · finished 2026-09-22 06:44:50.067692 UTC

1. Composite Trajectory Verdict

For a capital-intensive telecommunications provider executing multiple large acquisitions, all three statements carry roughly equal weight: the income statement shows earnings quality, the cash flow statement reveals funding capacity for network investment and shareholder returns, and the balance sheet reflects leverage dynamics from acquisition financing.

Composite Trajectory: Mixed

Revenue and operating cash flow are improving: total revenue grew 8.5% year-over-year to $88.3B (10-K 2025-12-31, Consolidated Statements of Comprehensive Income) and net cash from operations rose 25.4% to $27.95B (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, net income declined 3.1% to $11.0B (10-K 2025-12-31, Consolidated Statements of Comprehensive Income) and operating income grew only 1.5% to $18.3B, indicating margin compression. The balance sheet shows deteriorating leverage: total debt increased to ~$86.3B from ~$78.3B while equity fell 4.1% to $59.2B (10-K 2025-12-31, Consolidated Balance Sheets). Heavy acquisition spending ($17.6B investing outflow vs $9.1B prior year) drives the mixed picture.

2. Red Flags

  • Net income declined $347M (3.1%) despite 8.5% revenue growth, with operating margin contracting from 22.1% to 20.7% (10-K 2025-12-31, Consolidated Statements of Comprehensive Income)
  • Total debt increased ~$8B (10.2%) while stockholders' equity decreased $2.5B (4.1%), raising leverage (10-K 2025-12-31, Consolidated Balance Sheets)
  • Investing cash outflows nearly doubled to $17.6B from $9.1B, driven by $3.5B acquisitions, $4.1B JV investments, and $2.6B spectrum purchases (10-K 2025-12-31, Consolidated Statements of Cash Flows)
  • Merger-related costs recur across periods: $263M UScellular costs in 2025 vs $26M in 2024; Sprint costs $121M in 2024 vs $1.0B in 2023 (10-K 2025-12-31, MD&A – UScellular Merger-Related Costs and Sprint Merger-Related Costs)
  • $278M impairment of capitalized billing software in 2025 with no prior-year comparable (10-K 2025-12-31, Consolidated Statements of Comprehensive Income)
  • Adjusted Free Cash Flow margin declined 100 bps to 25% despite 6% AFCF growth (10-K 2025-12-31, MD&A – Adjusted Free Cash Flow)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Total revenue increased 8.5% to $88.3B in 2025 from $81.4B in 2024 (10-K 2025-12-31, Consolidated Statements of Comprehensive Income). Postpaid revenues grew 11% to $57.9B while wholesale revenues fell 16% to $2.9B. Operating income rose only 1.5% to $18.3B as total operating expenses increased 10.5% to $70.0B, outpacing revenue growth. Net income fell 3.1% to $11.0B from $11.3B, pressured by $363M higher net interest expense, $278M impairment charge, $390M workforce transformation costs, and $263M UScellular merger costs (10-K 2025-12-31, MD&A – Results of Operations). Effective tax rate was stable at 23.0% vs 22.9%.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash provided by operating activities grew 25.4% to $27.95B in 2025 from $22.29B in 2024, driven by a $4.6B improvement in working capital cash flows and $1.0B higher net income adjusted for non-cash items (10-K 2025-12-31, MD&A – Liquidity and Capital Resources). Capital expenditures increased 12.6% to $9.96B from $8.84B. Adjusted Free Cash Flow rose 5.7% to $17.99B from $17.03B (10-K 2025-12-31, MD&A – Adjusted Free Cash Flow). Investing outflows surged 94% to $17.61B due to $3.52B acquisitions, $4.06B JV investments, and $2.57B spectrum purchases. Financing outflows decreased 21% to $10.08B with $12.01B debt issuance offsetting $9.97B share repurchases, $6.20B debt repayments, and $4.12B dividends.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets grew 5.4% to $219.2B from $208.0B (10-K 2025-12-31, Consolidated Balance Sheets). Total liabilities increased 9.4% to $160.0B from $146.3B, with long-term debt rising 9.4% to $81.1B and short-term debt up 26.2% to $5.1B. Stockholders' equity declined 4.1% to $59.2B from $61.7B, driven by $9.97B share repurchases and $4.24B dividends exceeding $11.0B net income. Cash and equivalents were essentially flat at $5.6B vs $5.4B. Tower obligations decreased slightly to $3.5B from $3.7B. Operating lease liabilities were stable at $26.4B. The debt-to-equity ratio increased materially.

6. Data Gaps

  • Quarterly income statement, cash flow, and balance sheet data for 2026 quarters (Q1, Q2) and 2025 quarters (Q2, Q3) – the 10-Q filings are listed but their financial statement tables are not included in the provided text
  • Year-over-year quarterly comparisons for revenue, operating income, net income, operating cash flow, and leverage metrics
  • Detailed breakdown of 2026 capital expenditure guidance vs 2025 actuals
  • Post-acquisition integration cost trajectory for UScellular, Metronet, and Lumos beyond 2025
  • Quarterly churn, ARPU, and customer addition trends for 2026 periods
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status